Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia
about
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathwayDistinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptorsDiazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanismBlock by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclaseRole of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivityIn vitro analysis of the anti-inflammatory effect of inhomogeneous static magnetic field-exposure on human macrophages and lymphocytes.Persistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: a preliminary study on pain memory.A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats.Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain.A Short Peptide That Mimics the Binding Domain of TGF-β1 Presents Potent Anti-Inflammatory ActivityEndogenous morphine: opening new doors for the treatment of pain and addiction.Commensal microbiota is fundamental for the development of inflammatory pain.The nitroxyl donor, Angeli's salt, inhibits inflammatory hyperalgesia in rats.Teleantagonism: A pharmacodynamic property of the primary nociceptive neuron.Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway.Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A.Intracellular signaling in primary sensory neurons and persistent pain.Activation of the TRPV4 ion channel is enhanced by phosphorylation.Regulation of the spontaneous augmentation of Na(V)1.9 in mouse dorsal root ganglion neurons: effect of PKA and PKC pathways.Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.The role of PKA and PKCepsilon pathways in prostaglandin E2-mediated hypernociception.Intraplantar PGE2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases.Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues.An electronic pressure-meter nociception paw test for mice.Antinociception synergy between the peripheral and spinal sites of the heme oxygenase-carbon monoxide pathway.Skin vasodilation and analgesic effect of a topical nitric oxide-releasing hydrogel.Effect of bucladesine, pentoxifylline, and H-89 as cyclic adenosine monophosphate analog, phosphodiesterase, and protein kinase A inhibitor on acute pain.Antinociceptive and anti-hyperalgesic effects of bis(4-methylbenzoyl) diselenide in mice: evidence for the mechanism of action.Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models.
P2860
Q28344400-C1DE8006-1852-46E6-ADD1-A14CD9CBAE16Q28345071-85FD4DFD-2388-4F97-9B27-852A577D68FDQ28345788-D1D579B9-19BB-4D4B-8837-56EE68D7CC11Q28356452-FF8192A9-E81C-468C-9835-137DB524C4FDQ28363017-947B9416-4354-4F21-B653-F6F2E7B1542CQ31132849-0E783F9D-D4C9-4C6D-A2B5-572F330BF4E2Q33325626-1517747A-9F7D-4C0C-8335-B3B8BE210756Q33819799-D3865ADD-3C65-4213-80D3-6BAFE211077EQ35045518-958662C8-0DD5-4ECD-AA08-0D4E76E99AE2Q35048392-ED7DB456-0815-44DE-A13A-D6D1917D06FEQ35757103-13F26A32-7AE0-4D0C-B9B6-5857B30BC0BBQ36194064-14EE8EA6-8C1E-484B-9EF6-6E3749B08969Q36883155-06C675AB-784E-4FC4-90DC-99C00C7F966DQ36884713-ADD36D72-F39A-4D9B-AD48-814C3DCEDE5EQ37039381-ABD48F07-2E24-4EB3-B130-38F6CE2BA662Q37074756-C828BE53-7A6F-4917-B682-82BFA38C92ECQ37084924-62F463DB-238B-40C4-B1EE-DC14E0616094Q37144214-0B5258F2-FB23-4936-B082-0EF5B079A465Q37459860-56445EA6-12CD-439E-A709-68F2968A4D90Q40113375-36331A41-4C4E-49C2-B435-2BDDB341018CQ40373695-474F4FDE-8423-4CBD-93E5-28124C896486Q41424078-83C2A7BA-985D-40DC-BD6A-49823D3DDD0EQ41584404-8B087840-F325-498B-BE9E-86EBA8570E49Q41978727-A6E37111-702E-4004-A8CF-F2A122E1180EQ44827449-EE376BFD-C999-4F0F-BFBC-830F113386B0Q46121191-F492760B-2B94-43E7-8AFF-00169364A863Q46957313-6AA5BA71-1E32-46A9-A646-E3230F8412CCQ48154251-1282DCD9-1E91-4B72-864C-3A77C93A91E9Q53666895-9B6EA2D7-82A8-4CB2-9DA7-E4758C4902BEQ55245208-D74B5B0C-6E96-4224-B55E-1F4BA41D69C9
P2860
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@ast
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@en
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@nl
type
label
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@ast
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@en
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@nl
prefLabel
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@ast
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@en
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@nl
P2093
P2860
P3181
P356
P1476
Pharmacological modulation of ...... --on inflammatory hyperalgesia
@en
P2093
M M Teixeira
S H Ferreira
P2860
P3181
P356
10.1038/SJ.BJP.0702601
P407
P577
1999-06-01T00:00:00Z